FDA Investigator Tammara A Stephens

Tammara A Stephens has conducted inspections on 15 sites in 2 countries as of 22 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
15
Last Inspection Date:
22 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
100005430
Countries of Inspections:
United States of America, United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Tammara A Stephens:
Adam R Cooke, Althea A Williams, Amy H Ruble, Arie C Menachem, Babatunde D Babalola, Barbara M Frazier, Barbara T Carmichael, Billy M Battles, Bonita S Chester, Brandon C Heitmeier, Brandy D Brown, Brentley S Collins, Brooke K Higgins, Burnell M Henry, Calvin Foulks, Carlos M Gonzalez, CDR Ileana Barreto Pettit, CDR Thomas R Berry, PPh, Cherrie A Zachary, Cherry R Valerio, Christian D Lynch (CDL), Christie A Beatty, Christie B Rice, Christopher B May, Claire M Minden, Claudette D Brooks, Cordelia J Brammer, Cynthia Jim, CSO, Daphne Santiago, PhD, David J Gomes, Dawn M Braswell, Dellarese L Herbert, Denise M Digiulio, Dennis Cantellops Paite, Derek C Price, Devaughn Edwards, Donald C Obenhuber, PhD, Edward Deberry, Edward H Maticka, Eliezar Ramos, Erin C Hill, Erin Hill (EH), Fulton A Varner, Gabriel R Mclemore, Gamal A Norton, George J Flynn, Geraldine D Sanders, Gideon N Esuzor, Hector A Carrero, Helen R Bester, Ibad U Khan, Inga M Warr, Jacqueline Mdiaz Albertini, Jared P Stevens, Jason F Chancey, Jawaid Hamid, Jennifer D Hollstrom, Jennifer L Bridgewater, Jennifer Lalama, Joanne E King, Joseph F Owens, Julie D Bringger, Justin A Boyd, Karen A Coleman, Karen Gale Sego, Kathleen D Culver, Katrina B Mosley Sloan, Kimberly Cdelk Brooks, Kip J Hanks, Laiza V Garcia, Larry K Hampton, Latonya T Jiggetts, Laurel A Beer, Lawrence Carter, III, Lesley K Satterwhite, Leslie W Gilbert, LT Tamara J Henderson, Marc A Alston, Marian A Kainer, Marie F Morin, Marisa E Stock, Marvin D Jones, Mary A Millner, Melanie M Walker, Miaja Umaedi, Michele L Forster, PhD, Michelle Yclark Stuart, Mihaly S Ligmond, Monica Cburgos Garcia, Myoshi M Francis, Nancy G Schmidt, Nydia E Colon, Omotunde O Osunsanmi, Pal S Mayasandra, Patricia D Stahnke, Patricia F Hudson, Paul A Bonneau, Penny H Mccarver, Perry H Gambrell, Phillip M Pontikos, Prabhu P Raju, R Edwadebey Deberry, Randy L Clarida, Regina T Brown, Rhonda Alexander, Robert C Coleman, Ronnie E Jackson, Rose Ashley, Rozelle G Smith, Samantha J Bradley, Samuel L Murray, Saundrea A Munroe, Sayeeda Hdabe, Seneca D Toms, Shafiq S Ahadi, Sixto M Mercado Rios, Sonya M Edmonds, Stephanie E Hubbard, Stephen D Brown, Steven C Madzo, Steven D Dittert, Tamara M Casselman, Tamara M Felton, Tamika D Cathey, Tammara A Newberry, Thomas J Arista, Thomas R Withers, Trang N Cox, Trang P Nguyen, Travis E Chapman, Travis S Bradley, Vanessa E Coulter, Veronica Fuentes, MS, Vicky C Stoakes, Vincent M Williams, Viviana Matta, Xiomara Copeland, Yun Wu, PhD, Zhong Li, PhD

Tammara A Stephens's Documents

Publish Date Document Type Title
August, 2005 FDA 483 Artivion, Inc - Form 483, 2005-08-05
March, 2014 FDA 483 Artivion, Inc - Form 483, 2014-03-20
March, 2005 EIR Greer Laboratories, Inc. - EIR, 2005-03-03
March, 2005 FDA 483 Greer Laboratories, Inc. - Form 483, 2005-03-03
June, 2014 EIR Hospira, Inc. - EIR, 2014-06-13
June, 2010 FDA 483 Bausch & Lomb Incorporated - Form 483, 2010-06-25
March, 2014 FDA 483 Response Artivion, Inc - Form 483R, 2014-04-10
October, 2012 FDA 483 Artivion, Inc - Form 483, 2012-10-16
March, 2013 EIR Hospira, Inc. - EIR, 2013-03-01
May, 2009 FDA 483 Cardinal Health 414, LLC - Form 483, 2009-05-15
September, 2014 FDA 483 Patheon Manufacturing Services LLC - Form 483, 2014-09-12
March, 2013 FDA 483 Hospira, Inc. - Form 483, 2013-03-01
September, 2014 EIR Patheon Manufacturing Services LLC - EIR, 2014-09-12
May, 2024 FDA 483 WuXi AppTec Inc. - Form 483, 2024-05-02
August, 2007 FDA 483 Qualitest Pharmaceuticals - Form 483, 2007-08-08
August, 2018 FDA 483 Artivion, Inc - Form 483, 2018-08-08

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more